 
        
        
        Atractylodin is an active component of the essential oil contained in the rhizomes of Atractylodes lancea and A.
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 描述 | Atractylodin is an active component of the essential oil contained in the rhizomes of Atractylodes lancea and A. | 
| Concentration | Treated Time | Description | References | |
| HCT116 cells | 50 μM | 24 h | Determine the non-cytotoxic concentration of Atractylodin | Int J Mol Sci. 2023 Jan 2;24(1):802 | 
| HCT116 cells | 50 μM | 1 hour | Investigate the inhibitory effect of Atractylodin on TNF-α-induced NF-κB p65 phosphorylation | Int J Mol Sci. 2023 Jan 2;24(1):802 | 
| rat dorsal root ganglion neurons | 5 µM | 30 s | ATR induced a long-lasting calcium response, persisting for over 1 h | Int J Mol Sci. 2021 Mar 31;22(7):3614 | 
| hTRPA1-transfected HEK293 cells | 10 µM | 1 min | ATR induced long-lasting TRPA1 channel activation, persisting beyond 3 min after washout | Int J Mol Sci. 2021 Mar 31;22(7):3614 | 
| A549 cells | 0-100 μM | 24 h | To evaluate the effect of Atractylodin on TGF-β1-induced EMT in A549 cells, results showed that Atractylodin suppressed EMT-related protein expressions. | Int J Mol Sci. 2021 Oct 15;22(20):11152 | 
| RAW264.7 cells | 10, 20, 40 μM | 24 h | To investigate the inhibitory effect of Atractylodin on LPS-induced inflammatory response in macrophages. Results showed that Atractylodin significantly inhibited the mRNA expression of TNF-α, IL-1β, IL-6, and iNOS, and downregulated the phosphorylation levels of MAPK pathway proteins. | Front Pharmacol. 2021 Jul 15;12:665376 | 
| HCC827 lung cancer cells | 61.05 μM | 24 h | Cell viability was detected by the Cell Counting Kit-8 assay, and results showed that ATR could significantly inhibit the proliferation of HCC827 cells | Molecules. 2022 May 5;27(9):2946 | 
| NCI-H460 lung cancer cells | 63.27 μM | 24 h | Cell viability was detected by the Cell Counting Kit-8 assay, and results showed that ATR could significantly inhibit the proliferation of NCI-H460 cells | Molecules. 2022 May 5;27(9):2946 | 
| NCI-H23 lung cancer cells | 76.88 μM | 24 h | Cell viability was detected by the Cell Counting Kit-8 assay, and results showed that ATR could significantly inhibit the proliferation of NCI-H23 cells | Molecules. 2022 May 5;27(9):2946 | 
| A549 lung cancer cells | 37.92 μM | 24 h | Cell viability was detected by the Cell Counting Kit-8 assay, and results showed that ATR could significantly inhibit the proliferation of A549 cells | Molecules. 2022 May 5;27(9):2946 | 
| Administration | Dosage | Frequency | Description | References | ||
| Male SD rats | LPS-induced acute lung injury model | Gavage | 10 mg/kg, 40 mg/kg | Once daily for 7 days | To evaluate the therapeutic effects of ATL on acute lung injury. Results showed that ATL significantly reduced the lung wet/dry ratio, improved pathological changes, and lowered the expression levels of inflammatory factors TNF-α, IL-1β, IL-6, COX-2, and iNOS, as well as reduced neutrophil and macrophage aggregation. | iScience. 2024 Aug 31;27(10):110751 | 
| C57BL/6 mice | DSS-induced colitis model | Intraperitoneal injection | 40 mg/kg | Once daily for 14 days | Investigate the ameliorative effect of Atractylodin on colitis symptoms | Int J Mol Sci. 2023 Jan 2;24(1):802 | 
| Rats | Nociceptive behavior model | Intraperitoneal injection | 5 mg/kg | Single injection, assessed after 20 min | Systemic ATR application dose-dependently inhibited AITC-induced nociceptive behaviors | Int J Mol Sci. 2021 Mar 31;22(7):3614 | 
| C57B/6 male mice | Bleomycin-induced pulmonary fibrosis model | Intraperitoneal injection | 50 or 100 mg/kg | Once daily for 20 consecutive days | To evaluate the therapeutic effect of Atractylodin on bleomycin-induced pulmonary fibrosis, results showed that Atractylodin attenuated pulmonary fibrosis and reduced collagen deposition. | Int J Mol Sci. 2021 Oct 15;22(20):11152 | 
| Mice | Klotho-deficient and SAMP8 mice | Oral | 1 mg/kg | Daily administration | Atractylodin significantly prolonged the survival of klotho-deficient mice, ameliorated several age-related diseases, and reduced microglial activation in the brain | Mol Psychiatry. 2016 Nov;21(11):1613-1623 | 
| Wistar rats | AH-130 ascites hepatoma tumor-bearing rats | Oral | 1 mg/kg | Daily administration | Atractylodin significantly prolonged the median survival time of tumor-bearing rats. | Transl Psychiatry. 2011 Jul 26;1(7):e23 | 
| BALB/c mice | DSS-induced ulcerative colitis model | Intraperitoneal injection | 10 or 20 mg/kg | Once daily for 7 days | To evaluate the therapeutic effects of Atractylodin on DSS-induced ulcerative colitis. Results showed that Atractylodin significantly improved symptoms such as weight loss, disease activity index score, and colon length shortening, and inhibited macrophage activation and inflammatory cytokine production in colon tissues. | Front Pharmacol. 2021 Jul 15;12:665376 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 5.49mL 1.10mL 0.55mL | 27.44mL 5.49mL 2.74mL | 54.88mL 10.98mL 5.49mL | |
| CAS号 | 55290-63-6 | 
| 分子式 | C13H10O | 
| 分子量 | 182.22 | 
| SMILES Code | C/C=C/C#CC#C/C=C/C1=CC=CO1 | 
| MDL No. | MFCD01075143 | 
| 别名 | Atractydin | 
| 运输 | 蓝冰 | 
| InChI Key | GRBKWAXRYIITKG-QFMFQGICSA-N | 
| Pubchem ID | 5321047 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C | 
| 溶解方案 | DMSO: 5 mg/mL(27.44 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1